Top compounds associated with response to MAP1LC3B2

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	selumetinib:navitoclax (8:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.15	2e-05
mRNA	ABT-737	CTRPv2	pan-cancer	AAC	-0.14	0.0001
mRNA	selumetinib:tretinoin (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.13	0.0002
mRNA	selumetinib:piperlongumine (8:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.13	0.0003
mRNA	tretinoin:navitoclax (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.12	0.0003
mRNA	selumetinib:UNC0638 (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.12	0.0008
mRNA	ABT-263	CTRPv2	pan-cancer	AAC	-0.12	0.0008
mRNA	ABT-199	CTRPv2	pan-cancer	AAC	-0.14	0.001
mRNA	BRD-A02303741:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.11	0.001
mRNA	BRD-K71935468	CTRPv2	pan-cancer	AAC	-0.12	0.001

Download CSV